Print This Page Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients Siegfried Posts Higher Earnings and RevenuesCodexis, Arch Pharmalabs Expand Pharma Manufacturing DealDSM Biologics to Produce Antibody for MorphoSysRoche Sells Four Products to Swedish FirmFTC Clears Sun Pharma’s Offer to Buy Taro Related Stories Glenmark Buys Czech Pharma FirmIndian Firm is First to Join USP Verification ProgramIPS Opens Two Service Offices in IndiaIndia Faces Challenges to Growth, Including Competition from ChinaLeading Indian Pharma Companies Maintain Strong Growth

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

April 25, 2007

Alembic Completes Acquisition of Dabur Pharma

DR

Pharmaceutical company Alembic (Vadodara, India) says it has completed the acquisition of the non-oncology formulation business of Dabur Pharma (New Delhi) for approximately $37 million. Alembic acquired full rights to market...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers